Donaldson Inc Stock Price, News & Analysis

Donaldson (NYSE: DCI) will webcast its first quarter fiscal 2026 earnings conference call on Thursday, December 4, 2025 at 9:00 a.m. CT. Investors can listen live via the company’s Investor Relations site at IR.Donaldson.com under “Events & Presentations.”

A replay will be posted in the same section beginning at approximately 12:00 p.m. CT on December 4, 2025. Donaldson operates three primary business segments: Mobile Solutions, Industrial Solutions, and Life Sciences. For media or investor inquiries contact Sarika Dhadwal at (952) 887-3753 or Sarika.Dhadwal@Donaldson.com.

Ginkgo Bioworks (NYSE: DNA) was awarded a BARDA BioMaP-Consortium project agreement on November 3, 2025 to develop cost-reducing, scalable domestic biomanufacturing innovations for monoclonal antibodies (mAbs) against filoviruses such as Ebola (EBOV) and Sudan virus (SUDV).

The contract value is up to $22.2 million. Ginkgo will lead a partner team (Advanced BioScience Laboratories, Isolere Bio by Donaldson, NeuImmune, and ProteoNic) to integrate technologies across the mAb production process and to produce an anti-filovirus mAb cocktail (1C3 and 1C11) discovered at Emory University. The project is funded in whole or in part by BARDA/ASPR under OT number 75A50123D00003.

Donaldson (NYSE: DCI) announced that Tod Carpenter, chairman, president, and CEO, will present at the Gabelli Funds 49th Annual Automotive Aftermarket Symposium on Monday, November 3, 2025 at 3:00 p.m. PDT. A live webcast will be available via the company’s Investor Relations site under Events & Presentations at IR.Donaldson.com.

The release notes Donaldson’s global position in filtration products across three segments: Mobile Solutions, Industrial Solutions, and Life Sciences, and directs investors to additional company information at Donaldson.com.

Donaldson Company (NYSE: DCI), a global filtration technology leader, announced upcoming presentations at two major investor conferences. Chairman, President, and CEO Tod Carpenter will present at the Jefferies 2025 Industrials Conference on September 3, 2025, at 9:30 a.m. ET. Additionally, CFO Brad Pogalz will present at the Morgan Stanley 13th Annual Laguna Conference on September 10, 2025, at 4:05 p.m. ET.

Both presentations will be available via live webcast through Donaldson's Investor Relations website, with replays accessible for approximately 90 days following each event.

Donaldson Company (NYSE:DCI) reported strong Q4 and full-year fiscal 2025 results, with Q4 sales reaching $981 million, up 4.8% year-over-year, and Q4 GAAP EPS of $0.97, up 7.8%. For fiscal 2025, the company achieved total sales of $3.7 billion, a 2.9% increase, though GAAP EPS declined 9.8% to $3.05. The company returned $465 million to shareholders through dividends and share repurchases.

Looking ahead to fiscal 2026, Donaldson projects record performance with guidance centered on sales of $3.8 billion and EPS of $4.00. The company expects sales growth of 1-5%, operating margin between 16.1-16.7%, and plans to repurchase 2-3% of outstanding shares.

Donaldson Company (NYSE: DCI), a global leader in filtration products and solutions, has announced its fourth quarter 2025 earnings conference call, scheduled for Wednesday, August 27, 2025, at 9:00 a.m. CT.

The live webcast will be accessible through the "Events & Presentations" section of Donaldson's Investor Relations website at IR.Donaldson.com. A replay will be available at approximately 12:00 p.m. CT on the same day.

Founded in 1915, Donaldson operates through three primary segments: Mobile Solutions, Industrial Solutions, and Life Sciences, serving customers across six continents with over 140 locations worldwide.

Purilogics, a Donaldson Life Sciences (NYSE:DCI) business, has launched its first manufacturing-grade product, Purexa™ NAEX Prep membrane technology, designed for biopharmaceutical purification processes. The product, specifically created for purifying supercoiled plasmid DNA, offers high binding capacity, fast cycle times, and an efficient, scalable format.

Manufacturing takes place in an ISO 9001, Class 7 cleanroom certified facility in Bloomington, Minnesota, while R&D occurs in Greenville, South Carolina. The company plans to release additional research-grade and manufacturing-grade products within the Purexa membrane chromatography portfolio throughout 2025 and 2026.

Donaldson Company (NYSE: DCI) has declared a quarterly cash dividend of 30.0 cents per share, payable on August 27, 2025, to shareholders of record as of August 12, 2025.

The company, a global leader in filtration products and solutions, maintains its position in the S&P High-Yield Dividend Aristocrats Index, having increased its dividend for 29 consecutive years. Notably, Donaldson has maintained its quarterly dividend payments for 69 years, demonstrating a strong commitment to shareholder returns.

Donaldson Company (NYSE:DCI) has formed a strategic partnership with Mighty Distributing System of America to expand its heavy-duty filtration solutions distribution. The collaboration combines Donaldson's OE-grade filtration expertise with Mighty's inventory management services, targeting HD fleet facilities, diesel repair centers, and off-highway operations.

The partnership aims to serve a market of over 15 million Class 7 and 8 trucks in the U.S., with the heavy-duty parts aftermarket projected to reach $92.7 billion in 2025. Mighty will provide localized inventory support and premium Donaldson filtration products, including air, oil, fuel, and hydraulic filters, helping facilities reduce surplus stock and improve equipment uptime.